59
Kohnan Hospital Department of Neuroendovascular Therapy Yasushi Matsumoto Tohoku University Graduate School of Medicine Department of Neurosurgery Hidenori Endo, Teiji Tominaga 27 th Society of Neurosurgeons of South Africa Congress 2018

Yasushi Matsumoto · 2019. 1. 21. · Rhoton AL. Neurosurgery, 2002/ Takahashi S et al. AJNR, 1990/ Zeal AA et al. JNS, 1978 The perforating branches of the AChA passing through the

  • Upload
    others

  • View
    1

  • Download
    0

Embed Size (px)

Citation preview

  • Kohnan HospitalDepartment of Neuroendovascular Therapy

    Yasushi Matsumoto

    Tohoku University Graduate School of Medicine

    Department of NeurosurgeryHidenori Endo, Teiji Tominaga

    27th Society of Neurosurgeons of South Africa Congress 2018

  • The Japanese Society of Neuroendovascular Therapy

    COI Disclosure Information Yasushi Matsumoto

    I have the follwing financial relationships to disclose

    – Leadership position/advisory role for: GE health care, Fuji systems, Medicos Hirata, Stryker Corporation

    – Stockholder in : None

    – Patents and royalties from: None

    – Honoraria (lecture fee) from:

    • GE healthcare

    • Stryker Japan

    • Medico’s Hirata

    • Medtronic Japan

    • Century medical

    • Takeda Pharmaceutical Limited

    • Otuka Pharmaceutical Limited

    • Fuji systems

    – Honoraria (manuscript fee) from:

    – Grant/Research funding from: None

  • ✓Presurgical embolization of cerebral AVMs is

    effective, particularly for deep-seated cerebral AVMs

    ✓However, embolization of the choroidal arteries is

    challenging and potentially hazardous

    ➢Supply eloquent territories

    ➢Are of small caliber

    ➢Lack of collateral

    Embolization of choroidal arteries

  • Supplying territories of Choroidal arteries

    ❖ Anterior choroidal artery (AChA)

    Posterior limb of the internal capsule/Optic tract/

    Lateral geniculate body/ globus pallidus/cerebral peduncle

    ❖ Posterior choroidal artery (PChA)

    • Medial PChA

    Peduncle/tegmentum/geniculate body/colliculi/pulvinar/pineal gland/ medial thalamus

    • Lateral PChA

    Peduncle/posterior commissure/part of crura/body of the fornix/ lateral geniculate

    body/pulvinar/dorsomedial thalamic nucleus/body of the caudate nucleus

    Rhoton AL. Neurosurgery, 2002

  • Rhoton AL. Neurosurgery, 2002

    Anatomical course of AChA

    ❖ AChA arises distally to the PComAorigin

    ❖AChA can be divided into 2 segments1. cisternal segment2. plexal segment

  • Rhoton AL. Neurosurgery, 2002

    Cisternal segment

    Plexal segment

    ❖ AChA arises distally to the PComAorigin

    ❖ AChA can be divided into 2 segments1. cisternal segment2. plexal segment

    Anatomical course of AChA

    Plexal point

  • Anatomical course of AChA

    ❖Characteristics of the lateral angiogram of the ICA1. Cisternal segment : gentle S-shaped course2. Plexal point: steep downward course of a few millimeters,

    followed by a sharp posterior turn

    Plexal point

    Rhoton AL. Neurosurgery, 2002/ Takahashi S et al. AJNR, 1990/ Zeal AA et al. JNS, 1978

  • ICA BA

    Rhoton AL. Neurosurgery, 2002/ Takahashi S et al. AJNR, 1990/ Zeal AA et al. JNS, 1978

    ❖The perforating branches of the AChA passing through the anterior perforating substance to the globus pallidus and posterior limb of the internal capsule, arise from the cisternal segment and do not receive any significant collateral supply.

    ❖The catheter tip must be placed beyond the plexal point to avoid serious ischemic complications during AVM embolization through the AChA.

    Anatomical course of AChA

    Plexal point

    Plexal point= ≒ safety point

  • Rhoton AL. Neurosurgery, 2002Zeal AA et al. JNS, 1978

    ① Medial PChA・ origin: P2 > P1・ pineal body → velum interpositum

    → Monro → lateral ventricle・ like ‘3-shape’ in lateral view

    ② Lateral PChA・ origin: P2 > P3・ inferior horn/trigone

    → lateral ventricle

    LPChA

    MPChA

    Anatomical course of PChA

  • Rhoton AL. Neurosurgery, 2002Zeal AA et al. JNS, 1978

    BA

    PCA

    MPChA LPChA

    Anatomical course of PChANo angiotraphic ‘safety point’

    LPChA

    MPChA

  • The aims of this study

    To clarify the risk of complications in the endovascular embolization through the choroidal arteries

    Elkordy, Endo and Matsumoto. JNS, 2016

  • Methods(1)

    ❖ Inclusion criteria:

    – 116 consecutive patients with cerebral AVMs treated by endovascular embolization between 2006 and 2014

    – Patients who were treated by endovascular embolization through the AChA and/or PChA

    Trans arterial embolization:

    – General anesthesia

    – Embolic material:NBCA or Onyx

    – Marathon microcahteter

    – Chikai 10 or 008 microguidewireElkordy, Endo and Matsumoto. JNS, 2016

  • Methods(1)

    ❖ Inclusion criteria:

    – 116 consecutive patients with cerebral AVMs treated by endovascular embolization between 2006 and 2014

    – Patients who were treated by endovascular embolization through the AChA and/or PChA

    ❖ Trans arterial embolization:

    – General anesthesia

    – Embolic material:NBCA or Onyx

    – Marathon microcahteter

    – Chikai 10 or 008 microguidewire Elkordy, Endo and Matsumoto. JNS, 2016

  • Methods(2)

    ❖ Embolization was performed as a palliative procedure

    before open surgery or Gamma Knife radiosurgery.

    –when flow reduction by embolization of these arterial

    supplies was considered effective for surgical removal

    –necessary to obliterate intranidal or feeder aneurysms

    that were considered likely sites of hemorrhage before GK

    Elkordy, Endo and Matsumoto. JNS, 2016

  • Methods(3)

    ❖ Outcome evaluation:

    – Angiographic findings

    • Position of the microcatheter

    • Degree of the embolic agent reflux

    – Postop. MRI/CT

    • Hemorrhagic complications

    • Ischemic complications

    – Postop. neurological status

    – Final functional status: mRS

    ICA BA

    Plexal point

    Elkordy, Endo and Matsumoto. JNS, 2016

  • Methods(3)

    ❖ Outcome evaluation:

    – Angiographic findings

    • Position of the microcatheter

    • Degree of the embolic agent reflux

    – Postop. MRI/CT

    • Hemorrhagic complications

    • Ischemic complications

    – Postop. neurological status

    – Final functional status: mRS

    ICA BA

    Plexal point

    Elkordy, Endo and Matsumoto. JNS, 2016

  • Methods(3)

    ❖ Outcome evaluation:

    – Angiographic findings

    • Position of the microcatheter

    • Degree of the embolic agent reflux

    – Postop. MRI/CT

    • Hemorrhagic complications

    • Ischemic complications

    – Postop. neurological status

    – Final functional status: mRS

    ICA BA

    Plexal point

    Elkordy, Endo and Matsumoto. JNS, 2016

  • Results: 13/116 cases were included in this study

  • Results: all cases are ruptured AVMs

  • Results

    N (%)

    Target vessel

    AChA 8 (61%)

    PChA 6 (46%)

    Embolic agent

    NBCA 5 (38%)

    Onyx 8 (62%)

    Complications

    Hemorrhage 0 (0%)

    Ischemia 4 (31%)

    Symptoms

    Transient 1 (7.7%)

    Permanent 1 (7.7%)

    ❖ 13 cases were included in this study

  • Results

    N (%)

    Target vessel

    AChA 8 (61%)

    PChA 6 (46%)

    Embolic agent

    NBCA 5 (38%)

    Onyx 8 (62%)

    Complications

    Hemorrhage 0 (0%)

    Ischemia 4 (31%)

    Symptoms

    Transient 1 (7.7%)

    Permanent 1 (7.7%)

    ❖ 13 cases were included in this study

  • Results

    N (%)

    Target vessel

    AChA 8 (61%)

    PChA 6 (46%)

    Embolic agent

    NBCA 5 (38%)

    Onyx 8 (62%)

    Complications

    Hemorrhage 0 (0%)

    Ischemia 4 (31%)

    Symptoms

    Transient 1 (7.7%)

    Permanent 1 (7.7%)

    ❖ 13 cases were included in this study

  • Results

    N (%)

    Target vessel

    AChA 8 (61%)

    PChA 6 (46%)

    Embolic agent

    NBCA 5 (38%)

    Onyx 8 (62%)

    Complications

    Hemorrhage 0 (0%)

    Ischemia 4 (31%)

    Symptoms

    Transient 1 (7.7%)

    Permanent 1 (7.7%)

    ❖ 13 cases were included in this study

    Mortality: 0%

  • Results

    N (%)

    Target vessel

    AChA 8 (61%)

    PChA 6 (46%)

    Embolic agent

    NBCA 5 (38%)

    Onyx 8 (62%)

    Complications

    Hemorrhage 0 (0%)

    Ischemia 4 (31%)

    Symptoms

    Transient 1 (7.7%)

    Permanent 1 (7.7%)

    N (%)

    Additional Tx

    Resection 9 (69%)

    GK 3 (23%)

    Observation 1 (7.7%)

    Nidus obliteration

    Complete 10 (77%)

    Partial 3 (23%)

    ❖ 13 cases were included in this study

  • Results

    N (%)

    Target vessel

    AChA 8 (61%)

    PChA 6 (46%)

    Embolic agent

    NBCA 5 (38%)

    Onyx 8 (62%)

    Complications

    Hemorrhage 0 (0%)

    Ischemia 4 (31%)

    Symptoms

    Transient 1 (7.7%)

    Permanent 1 (7.7%)

    N (%)

    Additional Tx

    Resection 9 (69%)

    GK 3 (23%)

    Observation 1 (7.7%)

    Nidus obliteration

    Complete 10 (77%)

    Partial 3 (23%)

    ❖ 13 cases were included in this study

    Re-bleeding: 0%

  • 46F/ Ruptured, Lt. temporal AVM (SM grade IV)

    Preop. T2WI Working angle

    Plexal point

  • The MC tip was advanced distally to go beyond the angiographic plexal point

    Preop. T2WI Working angle

    Plexal point

    tip

  • Microangiography

    Plexal point

    catheter

  • 33% NBCA injection

  • 46F/ Ruptured, Lt. temporal AVM (SM grade IV)

    NBCA 33% Post-op. NBCA

    Pre POST

  • 46F/ Ruptured, Lt. temporal AVM (SM grade IV)

    DWI (POD1)Catheter position & reflux

  • Ischemic complication: No

    Additional treatment : Open surgery

    46F/ Ruptured, Lt. temporal AVM (SM grade IV)

  • 8 y.o. girl, ruptured AVM

    Rt. ICAG

    CT

  • AVM features

    Location: rt. temporal cortex – inferior hornFeeder:

    1. anterior choroidal a. 2. anterior temporal a.

    Drainer: 1. basal vein of Rosenthal2. vein of Labbe

    Intranidal aneurysm

    Spetzler & Martin Grade: 3 (S2D1E0)

  • TAEtarget: Intranidal aneurysm

    Inranidal AN

  • Marathon 1.5FChikai 10 + Mirage 0.008 inch

    Plexal point

    TAEtarget: Intranidal aneurysm

  • Marathon 1.5FChikai 10 + Mirage 0.008 inch

    Plexal point

    catheter

    TAEtarget: Intranidal aneurysm

  • Intranidal aneurysm has gone!

    Inranidal AN

  • TAEtarget: anterior temporal a.

    Marathon 1.5FChikai 10 + Mirage 0.008 inch

  • TAE (Onyx): plug and push

    Marathon 1.5FChikai 10 + Mirage 0.008 inch

  • pre

    Adequate presurgical embolization

  • Ischemic complication: No

    Additional treatment: Open surgery

    mRS score at 6Mos: 0

    8F/ Ruptured, Rt. temporal AVM (SM grade III)

    Onyx

  • 60M/ Ruptured, Rt. frontal AVM (SM grade II)

    Preop. T2WI

    Feeder AN→likely site of Hx.

  • 60M/ Rt. frontal AVM (SM grade II)

    Catheter positionWorking angle

    Plexal point Plexal point

    ANcatheter

  • 15% NBCA injection

    Catheter position

    NBCA 15%

    Working angle

    Plexal point Plexal point Plexal pointCast

    ANcatheter

  • 60M/ Ruptured, Rt. frontal AVM (SM grade II)

    DWI (POD1)Catheter position & reflux

    → Transient hemipareseis

  • Emolization-related morbidity: Transient hemiparesis

    Additional treatment: GK

    mRS score at 6Mos: 3

    60M/ Ruptured, Rt. frontal AVM (SM grade II)

  • 12F/ Ruptured, Rt. splenial AVM (SM grade II)

    Preop. T2WI Feeder: lateral PChA

  • Catheter positionWorking angle

    12F/ Ruptured, Rt. splenial AVM (SM grade II)

  • Catheter positionWorking angleOnyx 18

    12F/ Ruptured, Rt. splenial AVM (SM grade II)

  • DWI (POD1)

    12F/ Ruptured, Rt. splenial AVM (SM grade II)

  • DWI high lesion : Yes

    Emolization-related morbidity : No

    Additional treatment : Open surgery

    mRS score at 6Mos : 0

    46F/ Ruptured, Lt. temporal AVM (SM grade IV)

  • Discussions about AChA embolization

  • Case 2

    Case 5

    Case 8

    Case 3

    Case 7

    Case 6Case 4

    Case 1

  • Case 2

    Case 5

    Case 8

    Case 3

    Case 7

    Case 6Case 4

    Case 1

    Catheter tip position4/8: plexal segment 4/8: plexal segment: proximal to the Plexal point

  • Case 2

    Case 5

    Case 8

    Case 3

    Case 7

    Case 6Case 4

    Case 1

    Ischemic complication

    Ischemic complication

    No ischemic complication

    No ischemic complication

    Catheter tip position4/8: plexal segment 4/8: plexal segment: proximal to the Plexal point

  • Case 2

    Case 5

    Case 8

    Case 3

    Case 7

    Case 6

    Case 1

    Ischemic complication

    Ischemic complication

    No ischemic complication

    No ischemic complication

    Suggesting a potential collateral circulation

    Catheter tip position4/8: plexal segment 4/8: plexal segment: proximal to the Plexal point

  • Conclusions

    Elkordy, Endo and Matsumoto. JNS 2016

    ❖ Ischemic complications are possible following the

    embolization of cerebral AVMs through the choroidal artery,

    even with modern neurointerventional devices and techniques.

    ❖ Embolization through the choroidal artery may be an

    appropriate treatment option when the risk of surgery is

    considered to outweigh the risk of embolization.

  • Elkordy, Endo and Matsumoto. JNS May 6, 2016